|
S. No. |
Name of Product |
Composition |
|
1 |
Albendazole Oral Suspension IP 200 mg/5 ml |
Each 5 ml Contains: |
|
Albendazole IP 200 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
2 |
Aluminium, Magnesium and Simethicone oral Suspension IP (Antacid) |
Each 5 ml Contains: |
|
Aluminium Hydroxide Gel IP 250 mg |
||
|
Magnesium Hydroxide IP 250 mg |
||
|
Simethicone IP 50 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
3 |
Ambroxol Hydrochloride Syrup 30 mg/ 5 ml |
Each 5 ml contains: |
|
Ambroxol Hydrochloride IP 30 mg |
||
|
In Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
4 |
Cetirizine Syrup IP 5 mg/5 ml |
Each 5 ml Contains: |
|
Cetirizine HCl IP 5 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Tartrazine |
||
|
5 |
Cetirizine Oral Solution BP 5 mg |
Each 5 ml Contains: |
|
Cetirizine Hydrochloride BP 5 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
6 |
Chloroquine Phosphate Oral Suspension IP 50 mg/5 ml |
Each 5 ml Contains: |
|
Chloroquine Phosphate IP |
||
|
Equivalent to Chloroquine 50 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
7 |
Chloroquine Syrup IP 50 mg/5 ml |
Each 5 ml Contains: |
|
Chloroquine Phosphate IP |
||
|
Equivalent to Chloroquine 50 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Ponceau 4R Red |
||
|
8 |
Chlorpheniramine maleate Syrup 2 mg/ 5 ml |
Each 5 ml contains: |
|
Chlorpheniramine maleate IP 2 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
9 |
Chlorpromazine Hydrochloride Syrup 25 mg/ 5ml |
Each 5 ml contains: |
|
Chlorpromazine Hydrochloride IP |
||
|
25 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
10 |
Co- Trimoxazole Oral Suspension IP |
Each 5 ml Contains: |
|
Trimethoprim IP 40 mg |
||
|
Sulphamethoxazole IP 200 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
11 |
Co- Trimoxazole Oral Suspension IP |
Each 5 ml Contains: |
|
Trimethoprim IP 80 mg |
||
|
Sulphamethoxazole IP 400 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
12 |
Cyproheptadine Syrup IP 2 mg/5 ml |
Each 5 ml Contains: |
|
Cyproheptadine HCl IP 2 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
13 |
Chloramphenicol Oral Suspension IP 125 mg/ 5 ml |
Each 5 ml Contains: |
|
Chloramphenicol Palmitate IP |
||
|
Equivalent to |
||
|
Chloramphenicol 125 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour Used |
||
|
14 |
Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Syrup |
Each 5 ml Contains: |
|
Dextromethorphan |
||
|
Hydrobromide IP 10.00 mg |
||
|
Chlorpheniramine Maleate IP 2.00 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Carmosine Red |
||
|
15 |
Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, Guaiphenesin, and Ammonuim Chloride Syrup and Ammonuim Chloride Syrup |
Each 5 ml Contains: |
|
Dextromethorphan |
||
|
Hydrobromide IP 5.00 mg |
||
|
Chlorpheniramine Maleate IP 2.50 mg |
||
|
Guaiphenesin IP 50.00 mg |
||
|
Ammonium Chloride IP 60.00 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Carmosine Red |
||
|
16 |
Diphenhydramine HCl, Ammonium Chloride and Sodium Citrate Syrup |
Each 5 ml Contains: |
|
Diphenhydramine HCl IP 14.08 mg |
||
|
Ammonium Chloride IP 138.0 mg |
||
|
Sodium Citrate IP 57.03 mg |
||
|
In Mentholated Syrup Base Q.S. |
||
|
Colour: Caramel Black |
||
|
17 |
Diphenhydramine HCl, Ammonium Chloride, Sodium Citrate and Menthol Syrup |
Diphenhydramine HCl IP 15.0 mg |
|
Ammonium Chloride IP 150.0 mg |
||
|
Sodium Citrate IP 60.0 mg |
||
|
Menthol IP 1.0 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Caramel Black |
||
|
18 |
Disodium Hydrogen Citrate Syrup BP 1.4 gm/5 ml |
Each 5 ml Contains: |
|
Disodium Hydrogen Citrate BP 1.4 gm |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
19 |
Domperidone Suspension IP 1 mg/ml |
Each ml Contains: |
|
Domperidone IP 1.0 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Sunset Yellow |
||
|
20 |
Furazolidone Oral Suspension Suspension IP 25 mg/ 5 ml |
Each 5 ml contains: |
|
Furazolidone IP 25 mg |
||
|
In Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
21 |
Haloperidol Oral Solution IP 2 mg / 5 ml |
Each ml contains: |
|
Haloperidol IP 2 mg |
||
|
Aqua’s Base Q.S. |
||
|
22 |
Ibuprofen Oral Suspension 100 mg/5 ml |
Each 5 ml Contains: |
|
Ibuprofen IP 100 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
23 |
Lactulose Oral Syrup 10 gm/15 ml |
Each 15 ml Contains: |
|
Lactulose IP 10 gm |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Sunset Yellow |
||
|
24 |
Levocetirizine HCl Syrup 2.50 mg/5 ml |
Each 5 ml Contains: |
|
Levocetirizine HCl IP 2.50 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Tartrazine |
||
|
25 |
Levocetirizine HCl and Montelukast Sodium Syrup |
Each 5 ml Contains: |
|
Levocetirizine HCl IP 2.50 mg |
||
|
Montelukast Sodium IP 4.0 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Sunset Yellow |
||
|
26 |
Levosalbutamol, Ambroxol Hydrochloride and Guaiphenesin Syrup |
Each 5 ml Contains: |
|
Levosalbutamol Sulphate IP |
||
|
Equivalent to Levosalbutamol 1 mg |
||
|
Ambroxol Hydrochloride IP 30.00 mg |
||
|
Guaiphenesin IP 50.00 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
27 |
Levocetirizine Dihydrochloride Syrup 2.5 mg/ 5 ml |
Each 5 ml Contains: |
|
(Export Only) |
Levocetirizine Dihydrochloride USP 2.50 mg |
|
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour Used |
||
|
28 |
Mebendazole Oral Suspension 100 mg/5 ml |
Each 5 ml Contains: |
|
Mebendazole IP 100 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Sunset Yellow |
||
|
29 |
Metronidazole Benzoate Oral Suspension IP 40 mg/ml |
Each ml Contains: |
|
Metronidazole Benzoate IP |
||
|
Eq. to Metronidazole 40 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
30 |
Metronidazole Benzoate Oral Suspension IP 50 mg/ml |
Each ml Contains: |
|
Metronidazole Benzoate IP |
||
|
Eq. to Metronidazole 50 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
31 |
Metronidazole Benzoate Oral Suspension IP 100 mg/ 5 ml |
Each 5ml Contains |
|
Metronidazole Benzoate IP |
||
|
Equivalent to Metronidazole 100 mg |
||
|
In Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
32 |
Ofloxacin and Metronidazole Benzoate Oral Suspension |
Each 5 ml Contains: |
|
Ofloxacin IP 50 mg |
||
|
Metronidazole Benzoate IP |
||
|
Eq. to Metronidazole 100 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Sunset Yellow |
||
|
33 |
Ofloxacin Oral Suspension Suspension IP 50 mg/ 5 ml |
Each 5 ml contains: |
|
Ofloxacin IP 50 mg |
||
|
In Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
34 |
Ondansetron Syrup 2 mg/ 5 ml |
Each 5 ml contains: |
|
Ondansetron IP 2 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
35 |
Paracetamol Paediatric Oral Suspension IP 100 mg |
Each ml Contains: |
|
Paracetamol IP 100 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
36 |
Paracetamol Paediatric Syrup IP 125 mg/5 ml |
Each 5 ml Contains: |
|
Paracetamol IP 125 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
37 |
Paracetamol Paediatric Oral Suspension IP 125 mg/5 ml |
Each 5 ml Contains: |
|
Paracetamol IP 125 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
38 |
Paracetamol Paediatric Oral Suspension IP 150 mg/ml |
Each ml Contains: |
|
Paracetamol IP 150 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
39 |
Paracetamol Paediatric Oral Suspension IP 250 mg/ 5 ml |
Each 5 ml Contains: |
|
Paracetamol IP 250 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
40 |
Paracetamol Oral Suspension BP 250 mg/ 5 ml |
Each 5 ml Contains: |
|
(Export Only) |
Paracetamol BP 250 mg |
|
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour Used |
||
|
41 |
Paracetamol Oral Suspension BP 125 mg / 5 ml |
Each 5 ml Contains: |
|
(Export Only) |
Paracetamol BP 125 mg |
|
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour Used |
||
|
42 |
Pheniramine Maleate Syrup 15 mg/ ml |
Each ml Contains: |
|
Pheniramine Maleate IP 15 mg |
||
|
Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
43 |
Promethazine HCl Syrup IP 5 mg/5 ml |
Each 5 ml Contains: |
|
Promethazine HCl IP 5 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
44 |
Salbutamol Syrup IP 2 mg/ 5 ml |
Each 5 ml Contains |
|
Salbutamol Sulphate IP |
||
|
Equivalent to Salbutamol 2 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
45 |
Terbutaline Sulphate, Guaiphenesin, Ambroxol Hydrochloride and Menthol Syrup |
Each 5 ml Contains: |
|
Terbutaline Sulphate IP 2.50 mg |
||
|
Guaiphenesin IP 100.00 mg |
||
|
Ambroxol Hydrochloride IP 30.00 mg |
||
|
Menthol IP 2.50 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Carmosine Red |
||
|
46 |
Terbutaline Sulphate, Guaiphenesin, Ambroxol Hydrochloride and Menthol Syrup |
Each 5 ml Contains: |
|
Terbutaline Sulphate IP 1.250 mg |
||
|
Guaiphenesin IP 50.00 mg |
||
|
Ambroxol Hydrochloride IP 15.00 mg |
||
|
Menthol IP 2.500 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Carmosine Red |
||
|
47 |
Zinc Sulphate Oral Solution IP 20 mg/ 5 ml |
Each 5 ml Contains: |
|
Zinc Sulphate Monohydrate IP |
||
|
Eq. to elemental Zinc 20 mg |
||
|
Flavoured Syrup Base Q.S. |
||
|
Colour: Sunset Yellow |
||
|
48 |
Acyclovir Oral Suspension IP 200 mg/ 5 ml |
Each 5 ml contains: |
|
Acyclovir IP 200 mg |
||
|
In Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
49 |
Lactulose Solution USP 10 gm/ 15 ml |
Each 15 ml Contains: |
|
Lactulose Concentrate Solution USP |
||
|
Equivalent to Lactulose 10 gm |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
50 |
Paracetamol Syrup IP 250 mg/ 5ml |
Each 5 ml Contains: |
|
Paracetamol IP 250 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
51 |
Azithromycin Oral Suspension IP 100 mg/ 5 ml |
Each 5 ml Contains: |
|
Azithromycin IP (Dihydrate) |
||
|
Equivalent to Azithromycin |
||
|
Anhydrous 100 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
52 |
Azithromycin Oral Suspension IP 200 mg/ 5 ml |
Each 5 ml Contains: |
|
Azithromycin IP (Dihydrate) |
||
|
Equivalent to Azithromycin |
||
|
Anhydrous 200 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
53 |
Erythromycin Estolate Oral Suspension USP 100 mg |
Each 5 ml Contains: |
|
Erythromycin Estolate USP |
||
|
Equivalent to Erythromycin 100 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
54 |
Erythromycin Estolate Oral Suspension USP 125 mg |
Each 5 ml Contains: |
|
Erythromycin Estolate USP |
||
|
Equivalent to Erythromycin 125 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
55 |
Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension |
Each 5 ml Contains: |
|
Calcium Phosphate IP 240 mg |
||
|
(Equivalent to Calcium 82 mg) |
||
|
Cholecalciferol (D3) IP 200 IU |
||
|
Cyanocobalamine IP (B12) 2.500 mcg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Erythrosine Red |
||
|
56 |
Ferrous Ascorbate and Folic Acid Oral Suspension |
Each 5 ml Contains: |
|
Ferrous Ascorbate |
||
|
Equivalent to Elemental Iron 30 mg |
||
|
Folic Acid IP 550 mcg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
57 |
Ferrous Ascorbate and Folic Acid Oral Suspension |
Each 5 ml Contains: |
|
(Export Only) |
Ferrous Ascorbate |
|
|
Equivalent to Elemental Iron 30 mg |
||
|
Folic Acid BP 550 mcg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour Used |
||
|
58 |
Iron and Folic Acid Syrup IP 5 mg |
Each 5 ml Contains: |
|
Dried Ferrous Sulphate IP |
||
|
Equivalent to Elemental Iron 100 mg |
||
|
Folic Acid IP 0.5 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |
||
|
59 |
Prednisolone Sodium Phosphate Oral Solution BP 5 mg/ 5ml |
Each 5 ml Contains: |
|
Prednisolone Sodium Phosphate BP |
||
|
Eq. to Prednisolone 5 mg |
||
|
In Flavoured Syrup Base Q.S. |
||
|
Colour: Permitted Colour |
||
|
60 |
Vitamin A Paediatric Oral Solution IP 100000 IU/ ml |
Each ml Contains: |
|
Vitamin A Palmitate IP 100000 IU |
||
|
Flavoured Edible Oil Base Q.S. |
||
|
61 |
Vitamin B Complex Syrup |
Each 5 ml Contains: |
|
(For Prophylactic Use) |
Thiamin HCl IP (B1) 1.0 mg |
|
|
Riboflavine IP (B2) 1.0 mg |
||
|
Niacinamide IP (B3) 15.0 mg |
||
|
Pyridoxine HCL IP (B6) 0.5 mg |
||
|
Cyanocobalamine IP (B12) 0.500 mcg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
61 |
Vitamin B Complex with D-Panthenol Syrup |
Each 5 ml Contains: |
|
(For Prophylactic Use) |
Thiamin HCl IP (B1) 1.0 mg |
|
|
Riboflavine IP (B2) 1.0 mg |
||
|
Niacinamide IP (B3) 15.0 mg |
||
|
Pyridoxine HCL IP (B6) 1.0 mg |
||
|
D-Panthenol IP 1.000 mg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Approved Colour Used |
||
|
63 |
Iron, Folic Acid and Vitamin B12 Syrup |
Each 15 ml Contains: |
|
(Napo Fefo-up) |
Ferric Ammonium Citrate USP |
|
|
(Export Only) |
Equivalent to Elemental Iron 32 mg |
|
|
Folic Acid BP 0.5 mg |
||
|
Cyanocobalamin BP 7.5 mcg |
||
|
In Flavored Syrup Base Q.S. |
||
|
Colour: Approved Colour |